India’s Interim Budget Pushes Innovation, Green Production, HPV Vaccination

India’s interim budget 2024 hikes allocation for production-linked incentive schemes in pharmaceuticals, supports biotech start-ups - particularly green ones- and sets the right note for inclusion of HPV vaccination in the country’s Universal Immunization Program, one of the world's largest public health programs. How does it help?

India Budget
India's Interim Budget Focuses On Self-Reliance, Startups, Vaccines • Source: Shutterstock

India’s interim budget 2024 furthers the government’s push for self-reliance with a hike in the allocation for production-linked incentive (PLI) schemes related to pharmaceuticals, support for green bio-production processes and innovation, as well as growth of medical colleges.

In continuation of a focus on specific diseases, like on sickle cell anemia in the fiscal year 2023-24 budget, this time the interim budget spoke about encouraging vaccination for nine to 14-year-old girls against

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from India

More from Asia